There have been many reactions to the retrospective study identifying sildenafil (Viagra) as a candidate drug for Alzheimer’s disease that has just be...
A recent article in the November 24 issue of Fierce Healthcare summarizes results from value-based care from the insurer Humana in their latest annual...
Biogen’s Aducanumab has just received FDA approval for the treatment of Alzheimer’s Disease. During clinical trials of the drug the most common advers...
As we know, the evaluation of clinical benefits achieved with cancer drugs is a complex problem. It is well described in two recent reviews, a study t...
I have received a number of comments to my previous (Blog 4), including one by Dr. Indersen Gandhi, a medical consultant in pharmaceutical medicine fr...
Currently, offers of payment to volunteers participating in clinical trials come in three categories, reimbursement for-out-of-pocket expenses, compen...
Actu-Real offers solutions and services to help payers, providers and pharmaceutical companies optimize objectives of access, quality and cost of healthcare, with the backbone of a fit-for-purpose, all-in-one technology platform for data integration, advanced analytics, reporting and visualization.
Find Us on Social Platforms